ICCM News and Press, IceCure Medical Ltd. From 08/28/25

A look at the top 10 most actives in the United States Erayak Power Solution Group Inc. (RAYA) rose 22.6% to $0.0576 on volume of 241,031,156 shares Top KingWin Ltd (WAI) rose 52.4% to $0.2133 on volume of 155,769,781 shares CaliberCos Inc. (CWD) rose 83.3% to $3.1154 on volume of 95,928,70...

2025-08-15 08:15:10 ET H.C. Wainwright analyst issues BUY recommendation for ICCM on August 15, 2025 10:18AM ET. The previous analyst recommendation was Buy. ICCM was trading at $0.8416 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...

2025-08-13 16:15:09 ET Brookline Capital analyst issues BUY recommendation for ICCM on August 13, 2025 05:58PM ET. The previous analyst recommendation was Buy. ICCM was trading at $0.825 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cur...

2025-08-13 16:10:14 ET Kemp Dolliver from Loop Capital Markets issued a price target of $2.77 for ICCM on 2025-08-13 17:58:00. The adjusted price target was set to $2.77. At the time of the announcement, ICCM was trading at $0.825. The overall price target consensus is a...

2025-08-13 13:08:14 ET IceCure Medical Ltd (ICCM) Q2 2025 Earnings Conference Call August 13, 2025 10:00 AM ET Company Participants Michael Polyviou - IR, EVC Group Inc. Eyal Shamir - CEO & Director Ronen Tsimerman - CFO & COO Conference Call Partic...

2025-08-13 08:35:53 ET More on IceCure Medical IceCure Medical Ltd (ICCM) Q1 2025 Earnings Call Transcript IceCure Medical GAAP EPS of -$0.06 beats by $0.01, revenue of $0.73M misses by $0.25M IceCure Medical outlines post-market study plan for ProSense amid FDA enga...

IceCure Reports Financial & Operational Results for the First Half of 2025 IceCure Reports Financial & Operational Results for the First Half of 2025 PR Newswire $10 million two-times over-subscribed rights offering creates cash runway to anticipated FDA market...

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...

IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025

IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 PR Newswire CAESAREA, Israel , Aug. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasi...